Presentation
Engineering Cocrystal Solubility and Streamlining Cocrystal Early Development
29 Aug 2022
en
Confirming the absolute configuration and identifying crystal forms using high-resolution structural data and molecular architecture defined by advanced techniques like SCXRD and MicroED.
While industry success rates for single-crystal growth are typically limited, our specialized methodologies and crystallization strategies enable reliable results for complex drug molecules.
Utilizing two advanced diffractometers to support structure determination for the majority of crystalline samples.
Access to the National Synchrotron Light Source II for high-resolution data from challenging samples as small as 1–20 µm.
Applied to micro- and nanocrystals (typically <1 µm) when conventional X-ray methods are not feasible.
Have a question or need support with your project? Please complete the form, and our team will get back to you shortly.
Our capabilities span three specialized platforms:
Small Molecule
Crystal Bio Solutions
Crystal NAX
By providing your e-mail address, you agree to receive an e-mail response from Crystal Pharmatech to your inquiry. The information you submit will be governed by our Privacy Policy.
Subscribe to be the first to get the updates!